| Giao Quynh Le, MD | |
|
840 E Hill Ave, Moses Lake, WA 98837-2238 | |
| (509) 764-6400 | |
| (509) 764-6480 |
| Full Name | Giao Quynh Le |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 840 E Hill Ave, Moses Lake, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225200256 | NPI | - | NPPES |
| P01290337 | Other | WA | RR MEDICARE |
| 1225200256 | Medicaid | WA | |
| 0267242 | Other | WA | LABOR AND INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD60178353 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
The Washington Post: "The Food and Drug Administration this week began posting online the results of safety evaluations of recently approved drugs and vaccines. The action follows a law enacted in 2007 that requires the agency to provide more safety information to consumers and health professionals. The evaluations must be conducted 18 months after a new drug comes on the market.
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
Drugmaker Merck & Co. will pay Massachusetts $24 million to settle a civil lawsuit accusing a former subsidiary of causing the state to overpay pharmacists for a widely used asthma medication. Attorney General Martha Coakley said Tuesday that the deal with Merck and 12 other drugmakers who settled previously enables the state to recover more than $47 million for its Medicaid program.
Joint research between Kobe University and National Hospital Organization Kyushu Cancer Center has revealed that mice with mutations in the YAP signal pathway develop head-and-neck cancer over an extremely short period of time (world's fastest cancer onset mouse model), indicating that this pathway plays a crucial role in the onset of these cancers.
› Verified 2 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
The Washington Post: "The Food and Drug Administration this week began posting online the results of safety evaluations of recently approved drugs and vaccines. The action follows a law enacted in 2007 that requires the agency to provide more safety information to consumers and health professionals. The evaluations must be conducted 18 months after a new drug comes on the market.
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
Drugmaker Merck & Co. will pay Massachusetts $24 million to settle a civil lawsuit accusing a former subsidiary of causing the state to overpay pharmacists for a widely used asthma medication. Attorney General Martha Coakley said Tuesday that the deal with Merck and 12 other drugmakers who settled previously enables the state to recover more than $47 million for its Medicaid program.
Joint research between Kobe University and National Hospital Organization Kyushu Cancer Center has revealed that mice with mutations in the YAP signal pathway develop head-and-neck cancer over an extremely short period of time (world's fastest cancer onset mouse model), indicating that this pathway plays a crucial role in the onset of these cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Giao Quynh Le, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Giao Quynh Le, MD 840 E Hill Ave, Moses Lake, WA 98837-2238 Ph: (509) 764-6400 |
News Archive
The Washington Post: "The Food and Drug Administration this week began posting online the results of safety evaluations of recently approved drugs and vaccines. The action follows a law enacted in 2007 that requires the agency to provide more safety information to consumers and health professionals. The evaluations must be conducted 18 months after a new drug comes on the market.
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
Drugmaker Merck & Co. will pay Massachusetts $24 million to settle a civil lawsuit accusing a former subsidiary of causing the state to overpay pharmacists for a widely used asthma medication. Attorney General Martha Coakley said Tuesday that the deal with Merck and 12 other drugmakers who settled previously enables the state to recover more than $47 million for its Medicaid program.
Joint research between Kobe University and National Hospital Organization Kyushu Cancer Center has revealed that mice with mutations in the YAP signal pathway develop head-and-neck cancer over an extremely short period of time (world's fastest cancer onset mouse model), indicating that this pathway plays a crucial role in the onset of these cancers.
› Verified 2 days ago
Casey Michelle Celerian, Family Medicine Medicare: Medicare Enrolled Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Matthew Hardy, M.S., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 | |
Dr. Micheal Ryan Tolley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 | |
Ed Hoover, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-765-0216 | |
Dr. Kim Trong Nguyen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 Fax: 509-765-6591 | |
Cameron M. Beck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 Fax: 509-765-6591 | |
Jill Simon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 |